(NASDAQ: CRIS) Curis's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.91%.
Curis's earnings in 2025 is -$45,483,000.On average, 4 Wall Street analysts forecast CRIS's earnings for 2025 to be -$29,549,680, with the lowest CRIS earnings forecast at -$34,714,524, and the highest CRIS earnings forecast at -$19,812,679. On average, 3 Wall Street analysts forecast CRIS's earnings for 2026 to be -$22,663,504, with the lowest CRIS earnings forecast at -$32,597,784, and the highest CRIS earnings forecast at -$14,986,514.
In 2027, CRIS is forecast to generate -$13,970,479 in earnings, with the lowest earnings forecast at -$16,341,227 and the highest earnings forecast at -$11,599,731.